{
  "meta": {
    "id": "test25",
    "title": "Calcium Disorders - Hypercalcemia (Part 2)",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Shila, a 32-Year-Old female patient Came with C/O uremic symptoms, weakness, Fatigability, and depression. On investigation, her urea and creatinine levels are increased. A radiograph shows characteristic findings seen in her Spine What is your diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Paget\u2019s disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Osteoporosis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Osteopetrosis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hyperparathyroidism",
          "correct": true
        }
      ],
      "correct_answer": "D. Hyperparathyroidism",
      "question_images": [
        "https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1685617735156-QTDM041001IMG1.JPG"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Hyperparathyroidism A rugger jersey spine is distinctive of hyperparathyroidism Clinical signs associated with primary hyperparathyroidism are \u201cbones, stones, abdominal groans and psychic moans\u201d Calcitonin levels are increased in hyperparathyroidism; it is secreted by parafollicular c cells of thyroid gland In hyperparathyroidism, due to increase in PTH levels, osteoclast activity is increased, leading to increased calcium levels and ultimately high calcitonin levels.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A: \u2013Paget\u2019s disease More common in males Presents with bone pain, most commonly pelvis Investigation findings: serum calcium, phosphate (normal, increased alp) Radiological findings: lytic phase: blade of grass or candle flame appearance Mixed phase: picture frame vertebra, cotton wool skull Blastic- tam-o shanter skull Option: B: - osteoporosis Option: C: - osteopetrosis The patient presents with anemia, thrombocytopenia and leukopenia. An Erlenmeyer flask deformity is seen in this condition.</p>\n<p><strong>Extraedge:</strong></p><p>Radiographic changes in hyperparathyroidism: Subperiosteal bone resorption classically affects the radial aspects of the proximal and middle phalanges of the second and third fingers Osteopenia Rugger jersey spine Brown tumors Salt and pepper sign in a skull-pepper pot skull Terminal tuft erosion of phalanges</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "aeaf16e3",
      "audio": ""
    },
    {
      "text": "A 34-year-old male on treatment for bipolar disorder presents with hypercalcemia. What is the mechanism of hypercalcemia ?",
      "options": [
        {
          "label": "A",
          "text": "Hypoparathyroidism by increasing the sensitivity of the calcium sensing receptor",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hyperparathyroidism by reducing the sensitivity of the calcium sensing receptor",
          "correct": true
        },
        {
          "label": "C",
          "text": "Hyperparathyroidism by increasing parathyroid stimulating hormone from pituitary",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hypoparathyroidism by reducing parathyroid stimulating hormone from pituitary",
          "correct": false
        }
      ],
      "correct_answer": "B. Hyperparathyroidism by reducing the sensitivity of the calcium sensing receptor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Hyperparathyroidism by reducing the sensitivity of the calcium sensing receptor Lithium may cause hyperparathyroidism by reducing the sensitivity of the calcium sensing receptor. Lithium, used in the management of bipolar depression and other psychiatric disorders, causes hypercalcemia in 10% of treated patients. The hypercalcemia is dependent on continued lithium treatment, remitting and recurring when lithium is stopped and restarted.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A : Lithium may cause hyperparathyroidism by reducing the sensitivity of the calcium sensing receptor. Option C & D: The pituitary gland doesn\u2019t secrete hormones to control parathormone release.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e97ce1f4",
      "audio": ""
    },
    {
      "text": "Which of the following conditions presents with hypercalcemia with raised or normal PTH?",
      "options": [
        {
          "label": "A",
          "text": "Thyrotoxicosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Milk-alkali syndrome",
          "correct": false
        },
        {
          "label": "C",
          "text": "Familial hypocalciuric hypercalcemia",
          "correct": true
        },
        {
          "label": "D",
          "text": "Glucocorticoid deficiency",
          "correct": false
        }
      ],
      "correct_answer": "C. Familial hypocalciuric hypercalcemia",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Familial hypocalciuric hypercalcemia Familial hypocalciuric hypercalcemia is hypercalcemia with raised or normal PTH. Option A, B, and D: Hypercalcemia with low PTH.</p>\n<p><strong>Highyeild:</strong></p><p>with normal or elevated parathyroid hormone (PTH) levels \u25cf     Primary or tertiary hyperparathyroidism \u25cf     Lithium-induced hyperparathyroidism \u25cf     Familial hypocalciuric hypercalcaemia with low PTH levels \u25cf     Malignancy (lung, breast, myeloma, renal, lymphoma, thyroid) \u25cf     Elevated 1,25-dihydroxyvitamin D (vitamin D intoxication, sarcoidosis, human immunodeficiency virus, other granulomatous diseases) \u25cf     Thyrotoxicosis \u25cf     Paget's disease with immobilization \u25cf     Milk-alkali syndrome \u25cf     \u2022 Thiazide diuretics \u25cf     Glucocorticoid deficiency</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3e4904bf",
      "audio": ""
    },
    {
      "text": "With of clues from history and physical findings, a patient was diagnosed with hypercalcemia. This hypercalcemia was of chronic duration, i.e It lasted for many months. The clinical estimation of parathyroid hormone was made, and it was found to be high. What is your diagnosis?",
      "options": [
        {
          "label": "A",
          "text": "Primary hyperparathyroidism",
          "correct": false
        },
        {
          "label": "B",
          "text": "Malignancy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Milk alkali sunroom",
          "correct": false
        },
        {
          "label": "D",
          "text": "MEN syndrome",
          "correct": true
        }
      ],
      "correct_answer": "D. MEN syndrome",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>MEN syndrome Here the patient is a known case of hypercalcemia which is of chronic duration With the clinical estimation it is found that the patient is having a high parathyroid hormone levels This is only possible in men syndrome and hyperparathyroidism which is not primary. This is based on the algorithm for the evaluation of patients with hypercalcemia.</p>\n<p><strong>Highyeild:</strong></p><p>Clinical Gene Protein Mutation MEN 1 MEN Menin MEN 2A RET Proto-oncogene CRET MEN 4 CDKN1B p27 Familial Isolated HPT MEN; CASR; CGM2 CGM motif 2 HPT - Jaw Tumor Syndrome CDC 37 (or HPRT2) parafibromin</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A primary hyperparathyroidism In this question it is given that the hypercalcemia is of chronic duration; primarily the hyperparathyroidism comes under the diagnosis of acute duration, or when the duration is unknown. Option: B malignancy Malignancy is estimated based on the evaluation of its duration, whether it is acute or unknown. But in the question, it is given: chronic duration Option: C milk alkali syndrome Milk alkali syndrome also comes under the category of hypercalcemia. But the clinical estimation shows that the parathyroid hormone is high in the patient. In milk alkali syndrome, parathyroid hormone is low.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "465bf0cd",
      "audio": ""
    },
    {
      "text": "The patient, who is 27 years old, has a known diagnosis of sarcoidosis. Recently, he was brought to the emergency department with complaints of bone pain and There was fatigue and lethargy noted in the patient. What will you do next?",
      "options": [
        {
          "label": "A",
          "text": "Dialysis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Glucocorticoids",
          "correct": true
        },
        {
          "label": "C",
          "text": "oral phosphate",
          "correct": false
        },
        {
          "label": "D",
          "text": "denosumab",
          "correct": false
        }
      ],
      "correct_answer": "B. Glucocorticoids",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Glucocorticoids In the question, it is given that the patient is a known case of sarcoidosis. And he is developing sudden bone pain and lethargy. This means that there must be a diagnosis of hypercalcemia in this patient. With sarcoidosis, this is a special condition which is associated with hypercalcemia. In this special condition the drug of choice will be glucocorticoids. Onset of action is within days and advantage is that it is given as oral therapy for the drug of choice in sarcoidosis with hypercalcemia is glucocorticoids.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A -Dialysis Dialysis is useful in renal failure and can immediately reverse life-threatening hypercalcemia. But in the question, renal failure is not given. Option: C -Oral phosphate This is given in the management of chronic hypophosphatemia. Here, there is no mention of symptoms of hypophosphatemia. Option: D-Denosumab This is a strongest anti-resorptive agen t useful for the treatment of hypercalcemia, and it is also one of the new drugs in the treatment of hypercalcemia. However, here the patient is having sarcoidosis. Hence, the drug of choice is glucocorticoids.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0b4e1365",
      "audio": ""
    },
    {
      "text": "The patient, a female, 43 years old, is a known breast cancer patient. She suddenly developed lethargy and she was brought to the emergency department. She was not able to tell the time and place properly. Patient also complained that she was passing a large amount of urine. What will you do next?",
      "options": [
        {
          "label": "A",
          "text": "Volume expansion",
          "correct": true
        },
        {
          "label": "B",
          "text": "Loop diuretics",
          "correct": false
        },
        {
          "label": "C",
          "text": "Zoledronic acid",
          "correct": false
        },
        {
          "label": "D",
          "text": "Denosumab",
          "correct": false
        }
      ],
      "correct_answer": "A. Volume expansion",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Volume expansion The patient is a known breast carcinoma patient. The clinical findings and the recent findings of polyuria and polydipsia in the patient is consistent with the finding of hypercalcemia. This is termed as hypercalcemia of militancy where there is lytic skeletal metastasis due to the breast carcinoma in the patient. Hence, we have to look into the treatment of hypercalcemia. Mild asymptomatic hypercalcemia does not require immediate therapy,. but here there is neurological involvement this means that the hypercalcemia is severe Initial therapy of significant hypercalcemia begins with volume expansion because hypercalcemia invariably lead to dehydration which can be life threatening.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: B Loop diuretics Here, the primary focus is to correct the dehydration through volume expansion. Loop diuretics are used to enhance sodium and calcium excretion. However, this should not be initiated until the volume status has been restored to normal Option: C Zoledronic acid This is a bisphosphonate that is commonly used in the treatment and hypercalcemia of malignancy in adults. The onset of action is within one to 3 days. Here there is an emergency condition: Hence, volume expansion should be considered first. Option: D. Denosumab More recently, this potent inhibitor of bone resorption, denosumab, has also been shown to be effective in treating hypercalcemia that is refractory to bisphosphonates.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0120f88a",
      "audio": ""
    }
  ]
}